Publicaciones en colaboración con investigadores/as de Washington University in St. Louis School of Medicine (52)

2024

  1. CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease

    Alzheimer's and Dementia, Vol. 20, Núm. 9, pp. 6205-6220

  2. DNA methylation and stroke prognosis: an epigenome-wide association study

    Clinical Epigenetics, Vol. 16, Núm. 1

  3. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project

    Gut Microbes, Vol. 16, Núm. 1

  4. Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies

    Fluids and Barriers of the CNS, Vol. 21, Núm. 1

  5. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Epigenetic Clock Explains White Matter Hyperintensity Burden Irrespective of Chronological Age

    Biology, Vol. 12, Núm. 1

  3. Machine Learning Approximations to Predict Epigenetic Age Acceleration in Stroke Patients

    International journal of molecular sciences, Vol. 24, Núm. 3

  4. Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning

    Genome Medicine, Vol. 15, Núm. 1

  5. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Biological Age Acceleration Is Lower in Women With Ischemic Stroke Compared to Men

    Stroke, Vol. 53, Núm. 7, pp. 2320-2330

  2. Cardiac and pulmonary findings in dysferlinopathy: A 3-year, longitudinal study

    Muscle and Nerve, Vol. 65, Núm. 5, pp. 531-540

  3. Chronic Stroke Sensorimotor Impairment Is Related to Smaller Hippocampal Volumes: An ENIGMA Analysis

    Journal of the American Heart Association, Vol. 11, Núm. 10, pp. e025109

  4. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

    Acta Neuropathologica, Vol. 144, Núm. 5, pp. 821-842

  5. Genotype-phenotype correlations in valosin-containing protein disease: a retrospective muticentre study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 93, Núm. 10, pp. 1099-1111

  6. Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles

    Hepatology, Vol. 76, Núm. 4, pp. 1121-1134

  7. Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma

    Leukemia and Lymphoma, Vol. 63, Núm. 4, pp. 821-833

  8. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

    JAMA Neurology, Vol. 79, Núm. 3, pp. 228-243

  9. Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism

    The European respiratory journal, Vol. 59, Núm. 2

  10. Temporal order of clinical and biomarker changes in familial frontotemporal dementia

    Nature medicine, Vol. 28, Núm. 10, pp. 2194-2206